Skip navigation
Big Pharma keeps using R&D costs to justify high launch prices even after peer-reviewed research…
0:00 / 1:02

Big Pharma keeps using R&D costs to justify high launch prices even after peer-reviewed research…

Americans For Pharma Reform

@BustBigPharma5.6K followers

Visit on X

102,084 views

Big Pharma keeps using R&D costs to justify high launch prices even after peer-reviewed research found no association between the two. The argument persists because it protects profits and blocks reform. Rob Burgess follows the receipts.

Comments

Comments from the original post on X (Twitter)

No comments yet